Navigation Links
FDA Nanotechnology Task Force takes positive step forward

Today’s report from the Food and Drug Administration (FDA) Nanotechnology Task Force is an important and positive step forward in the agency’s effort to tackle the new scientific and regulatory challenges posed by nanotechnology.

The Task Force is clear and candid in acknowledging the pervasive potential of nanotechnology to affect virtually every product category FDA regulates—from pharmaceuticals and devices to cosmetics and food supplements— and in calling for a wide range of FDA actions to prepare for and execute its oversight role. While available evidence does not suggest that all materials with nanoscale dimensions will be hazardous, the Task Force correctly concludes that the agency needs new safety assessment tools, greater nano-specific staff expertise and more risk research to assess the likelihood of long-term health effects from exposure to specific nanoscale materials.

The report also recognizes the need to gather more information from industry, especially to answer safety-related questions, and to provide companies with clear guidance so there can be reasonable and safe pathways to market for the many potential applications of nanotechnology under FDA’s jurisdiction.

Equally important, the report signals FDA’s commitment to a transparent public process for developing its regulatory policies. Public participation will be key both to developing good policies and winning public confidence in the agency’s oversight of nanotechnology, and I applaud the Task Force and FDA for taking this approach.

Finally, the extensive nanotechnology “to do” list outlined in the report should remind Congress, as it considers FDA’s 2008 budget, that it needs to fix the problem of FDA’s chronic underfunding. The agency urgently needs more resources to do what needs to be done on nanotechnology—and do it urgently—along with the many other challenges the agency faces.   Source:Nanotechnologies


'"/>




Page: 1

Related medicine news :

1. CoQ10 bioavailability increased by Nanotechnology
2. Nanotechnology Revolution To Be Spearheaded By European Union
3. RNA Nanotechnology To Rescue Cancer Patients In Future
4. Scientists Consider About New Technology Called Nanotechnology
5. Potential Benefits Of New Nanotechnology
6. Nanotechnology Promises Huge Medical Benefits
7. Nanotechnology at its best: Nanomotors And Mechanical Nanoswitches
8. Nanotechnology Could Revolutionize Cardiac Treatment
9. Anti-Sense Drugs and Nanotechnology Offer New Hope In Cancer Fight
10. Nanotechnology – to detect and treat ovarian cance
11. Nanotechnology Used For Detecting Viruses
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... March 24, 2017 , ... ... spark a conversation on the current obstacles facing infection prevention and offer strategies ... deaths caused by these infections. , The print component of “Fighting Infection” ...
(Date:3/24/2017)... Dallas, Texas (PRWEB) , ... March 24, 2017 , ... ... Budget Office score is invalid because it does not obey the rules Congress has ... million full-time equivalent jobs, which the GOP reform would restore. Yet, it estimates a ...
(Date:3/24/2017)... Sedona, Arizona (PRWEB) , ... March 24, 2017 ... ... Shamangelic Healing Center, Sedona, Arizona’s Premier Center for Shamanic Healing and Spiritual Awakening, ... Jorge Luis Delgado, June 9--24, 2017. This sacred and spiritual journey during ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She ... Record, The majority of cases litigated under ERISA involve claims for long-term disability ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located in Southlake, ... leads programs. , In February, 2017, Empower Brokerage introduced their new “Performance Partners” ... designed to teach how to maximize their sales efforts, as well as how ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... PUNE, India , March 24, 2017 ... conjugates market has been growing rapidly as the global sales of ... Globally, the growth in the antibody drug conjugates market is driven ... incidences of cancer and wider therapeutic window offered by ADCs. ... Browse 3 Tables and ...
(Date:3/24/2017)... 2017  GenomeDx Biosciences today announced that six abstracts ... Prostate Cancer Classifier tests will be presented at the ... Congress held March 24 to 28, 2017 in ... is Europe,s largest urological event ... urological field. The abstract titled "Muscle invasive ...
(Date:3/24/2017)... Tenn. , March 23, 2017  Provectus ... or the "Company"), a clinical-stage oncology and dermatology ... announced Definitive Financing Commitment Term Sheet (the "Definitive ... a group of the Company,s stockholders, who are ... Group" in a Form 8-K filed with the ...
Breaking Medicine Technology: